Biognosis buys Abion to serve as research & development centre:
This article was originally published in Clinica
Executive Summary
Biognosis has bought the assets of Abion, of Julich, Germany, and formed a new German subsidiary, Biognosis. The UK company, which is developing serology tests for infectious diseases, says Abion's technology supports its development of high speed, quantitative immunoassays. The German subsidiary will serve as Biognosis' R&D centre. High Wycombe-based Biognosis, which is privately-funded, plans to spend DM10 million ($5.6 million) on development projects over the next four years. The first are expected in mid-1999.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.